These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 7862452)

  • 61. Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells.
    Ando K; Ajchenbaum-Cymbalista F; Griffin JD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9571-5. PubMed ID: 8415743
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CDK4 activity in mouse embryos expressing a single D-type cyclin.
    Ciemerych MA; Yu Q; Szczepanska K; Sicinski P
    Int J Dev Biol; 2008; 52(2-3):299-305. PubMed ID: 18311721
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
    Chen Q; Lin J; Jinno S; Okayama H
    Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.
    Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
    Biochem J; 2004 Mar; 378(Pt 2):673-9. PubMed ID: 14641107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.
    Warner BJ; Blain SW; Seoane J; Massagué J
    Mol Cell Biol; 1999 Sep; 19(9):5913-22. PubMed ID: 10454538
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pattern of expression of cyclin D1/CDK4 complex in human placenta during gestation.
    De Falco M; Fedele V; Cobellis L; Mastrogiacomo A; Giraldi D; Leone S; De Luca L; Laforgia V; De Luca A
    Cell Tissue Res; 2004 Aug; 317(2):187-94. PubMed ID: 15221443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
    Koff A; Ohtsuki M; Polyak K; Roberts JM; Massagué J
    Science; 1993 Apr; 260(5107):536-9. PubMed ID: 8475385
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression.
    Meyer CA; Jacobs HW; Datar SA; Du W; Edgar BA; Lehner CF
    EMBO J; 2000 Sep; 19(17):4533-42. PubMed ID: 10970847
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1.
    Hirai H; Sherr CJ
    Mol Cell Biol; 1996 Nov; 16(11):6457-67. PubMed ID: 8887674
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product.
    Soni R; Muller L; Furet P; Schoepfer J; Stephan C; Zumstein-Mecker S; Fretz H; Chaudhuri B
    Biochem Biophys Res Commun; 2000 Sep; 275(3):877-84. PubMed ID: 10973815
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK; Luo L; Medina D
    Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transforming growth factor-beta1 modulates p107 function in myeloid cells: correlation with cell cycle progression.
    Bang OS; Ruscetti FW; Lee MH; Kim SJ; Birchenall-Roberts MC
    J Biol Chem; 1996 Mar; 271(13):7811-9. PubMed ID: 8631825
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.
    Wang L; Wang J; Blaser BW; Duchemin AM; Kusewitt DF; Liu T; Caligiuri MA; Briesewitz R
    Blood; 2007 Sep; 110(6):2075-83. PubMed ID: 17537993
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors.
    Dao MA; Hwa J; Nolta JA
    Blood; 2002 Jan; 99(2):499-506. PubMed ID: 11781230
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice.
    Mettus RV; Rane SG
    Oncogene; 2003 Nov; 22(52):8413-21. PubMed ID: 14627982
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Meyerson M; Harlow E
    Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of CDK4 and p16INK4A in interleukin-6-mediated growth of multiple myeloma.
    Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Hoshi Y; DeCaprio JA; Anderson KC
    Leukemia; 1997 Nov; 11(11):1957-63. PubMed ID: 9369432
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats.
    Li JM; Poolman RA; Brooks G
    Am J Physiol; 1998 Sep; 275(3):H814-22. PubMed ID: 9724284
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes.
    Corroyer S; Maitre B; Cazals V; Clement A
    J Biol Chem; 1996 Oct; 271(41):25117-25. PubMed ID: 8810266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.